Activation of α7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures

Journal of Neuroinflammation

Volumn 2, Issue , 2005, Pages

  De Simone, Roberta ^a   Ajmone Cat, Maria Antonietta ^a   Carnevale, Daniela ^a   Minghetti, Luisa ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Brain macrophages; IL 10; Inflammation; Prostaglandin E2; TNF

Indexed keywords

BUNGAROTOXIN RECEPTOR; CYCLOOXYGENASE 2; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; NICOTINE; NICOTINIC RECEPTOR; NITRIC OXIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; CULTURE MEDIUM; IMMUNOFLUORESCENCE; INHIBITION KINETICS; MICROGLIA; NONHUMAN; PROSTAGLANDIN RELEASE; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RAT; RECEPTOR INTRINSIC ACTIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 18144395496     PISSN: 17422094     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-2-4     Document Type: Article

References (57)

1. Nathan C: Points of control in inflammation. Nature 2002, 420:846-852.
2. Perry VH, Newman TA, Cunningham C: The impact of systemic infection on the progression of neurodegenerative disease. Nat Rev Neurosci 2003, 4:103-112.
3. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ: Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000, 405:458-462.
4. Tracey KJ: The inflammatory reflex. Nature 2002, 420:853-859.
5. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ: Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003, 421:384-388.
6. Clementi F, Fornasari D, Gotti C: Neuronal nicotinic receptors, important new players in brain function. Eur J Pharmacol 2000, 42:3-10.
7. Marubio LM, Changeux J: Nicotinic acetylcholine receptor knockout mice as animal models for studying receptor function. Eur J Pharmacol 2000, 393:113-121.
8. Sharma G, Vijayaraghavan S: Nicotinic receptor signaling in nonexcitable cells. J Neurobiol 2002, 53:524-534.
9. Rogers SW, Gregori NZ, Carlson Gahring LC, Noble M: Neuronal nicotinic acetylcholine receptor expression by O2A/oligodendrocyte progenitor cells. Glia 2001, 33: 306-313.
10. Sharma G, Vijayaraghavan S: Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores. Proc Natl Acad Sci U S A 2001, 98:4148-4153.
11. Hosli E, Jurasin K, Ruhl W, Luthy R, Hosli L: Colocalization of androgen, estrogen and cholinergic receptors on cultured astrocytes of rat central nervous system. Int J Dev Neurosci 2001, 1:11-19.
12. Shytle RD, Mori T, Townsend K, Vendrame M, Sun N, Zeng J, Ehrhart J, Silver AA, Sanberg PR, Tan J: Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem 2004, 89:337-343.
13. Conti-Fine BM, Navaneetham D, Lei S, Maus AD: Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity? Eur J Pharmacol 2000, 393:279-294.
14. Wang Y, Pereira EF, Maus AD, Ostlie NS, Navaneetham D, Lei S, Albuquerque EX, Conti-Fine BM: Human bronchial epithelial and endothelial cells express alpha7 nicotinic acetylcholine receptors. Mol Pharmacol 2001, 60:1201-1209.
15. Matsunaga K, Klein TW, Friedman H, Yamamoto Y: Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine. J Immunol 2001, 167: 6518-6524.
16. Kawashima K, Fujii T: The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci 2003, 74:675-696.
17. Sopori M: Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002, 2:372-377.
18. Bruce-Keller AJ: Microglial-neuronal interactions in synaptic damage and recovery. J Neurosci Res 1999, 58: 191-201.
19. Streit WJ: Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 2002, 2:133-139.
20. Levi G, Patrizio M, Bernardo A, Petrucci TC, Agresti C: Human immunodeficiency virus coat protein gp120 inhibits the betadrenergic regulation of astroglial and microglial functions. Proc Natl Acad Sci U S A 1993, 90:1541-1545.
21. Minghetti L, Polazzi E, Nicolini A, Creminon C, Levi G: Interferon-gamma and nitric oxide down-regulate lipopolysaccharide-induced prostanoid production in cultured rat microglial cells by inhibiting cyclooxygenase-2 expression. J Neurochem 1996, 66:1963-1970.
22. Tanaka A, Hase S, Miyazawa T, Ohno R, Takeuchi K: Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events. J Pharmacol Exp Ther 2002, 303: 1248-1254.
23. Kawai H, Zago W, Berg DK: Nicotinic alpha 7 receptor clusters on hippocampal GABAergic neurons: regulation by synaptic activity and neurotrophins. J Neurosci b2002, 22: 7903-7912.
24. Jonnala RR, Buccafusco JJ: Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists. J Neurosci Res 2001, 66:565-572.
25. Minghetti L, Levi G: Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog Neurobiol 1998, 54:99-125.
26. Harris SG, Padilla J, Koumas L, Ray D, Phipps RP: Prostaglandins as modulators of immunity. Trends Immunol 2002, 23:144-150.
27. Minghetti L: Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 2004, 63:901-910.
28. De Simone R, Ajmone-Cat MA, Minghetti L: Atypical antiinflammatory activation of microglia induced by apoptotic neurons: possible role of phosphatidylserine-phosphatidylserine receptor interaction. Mol Neurobiol 2004, 29:197-212.
29. 2 protects cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res 1994, 663:237-243.
30. 2 or cAMP against microglial and neuronal free radical mediated toxicity associated with inflammation. J Neurosci Res 2002, 70:97-107.
31. McCullough L, Wu L, Haughey N, Liang X, Hand T, Wang Q, Breyer RM, Andreasson K: Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. J Neurosci 2004, 24: 257-268.
32. 2 and a beta-adrenergic agonist. Glia 1994, 11:383-386.
33. Bezzi P, Carmignoto G, Pasti L, Vesce S, Rossi D, Rizzino BL, Pozzan T, Volterra A: Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 1998, 391:281-285.
34. Hewett SJ, Uliasz TF, Vidwans AS, Hewett JA: Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture. J Pharmacol Exp Ther 2000, 293:417-425.
35. Takadera T, Yumoto H, Tozuka Y, Ohyashiki T: Prostaglandin E(2) induces caspase-dependent apoptosis in rat cortical cells. Neurosci Lett 2002, 317:61-64.
36. Levi G, Minghetti L, Aloisi F: Regulation of prostanoid synthesis in microglial cells and effects of prostaglandin E2 on microglial functions. Biochimie 1998, 80:899-904.
37. 2 in the central nervous system in response to brain injury and circulating lipopolysaccharide. J Neurochem 1994, 76:855-864.
38. De Simone R, Ajmone-Cat MA, Tirassa P, Minghetti L: Apoptotic PC12 cells exposing phosphatidylserine promote the production of anti-inflammatory and neuroprotective molecules by microglial cells. J Neuropathol Exp Neurol 2003, 62:208-216.
39. De Simone R, Ajmone-Cat MA, Nicolini A, Minghetti L: Expression of phosphatidylserine receptor and down-regulation of proinflammatory molecule production by its natural ligand in rat microglial cultures. J Neuropathol Exp Neurol 2002, 61: 237-244.
40. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM: Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998, 101:890-898.
41. Henson PM, Bratton DL, Fadok VA: The phosphatidylserine receptor: a crucial molecular switch? Nat Rev Mol Cell Biol 2001, 2:627-633.
42. Luth HJ, Apelt J, Ihunwo AO, Arendt T, Schliebs R: Degeneration of beta-amyloid-associated cholinergic structures in transgenic APP SW mice. Brain Res 2003, 977:16-22.
43. Picciotto MR, Zoli M: Nicotinic receptors in aging and dementia. J Neurobiol 2002, 53:641-655.
44. White HK, Levin ED: Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease. Psychopharmacology 1999, 143:158-165.
45. Court JA, Piggott MA, Lloyd S, Cookson N, Ballard CG, McKeith IG, Perry RH, Perry EK: Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication. Neuroscience 2000, 98:79-87.
46. Banerjee C, Nyengaard JR, Wevers A, de Vos RA, Jansen Steur EN, Lindstrom J, Pilz K, Nowacki S, Bloch W, Schroder H: Cellular expression of alpha7 nicotinic acetylcholine receptor protein in the temporal cortex in Alzheimer's and Parkinson's disease-a stereological approach. Neurobiol Dis 2000, 7:666-672.
47. Newhouse PA, Potter A, Kelton M, Corwin J: Nicotinic treatment of Alzheimer's disease. Biol Psychiatry 2001, 49: 268-278.
48. Prendergast MA, Harris BR, Mayer S, Holley RC, Hauser KF, Littleton JM: Chronic nicotine exposure reduces N-methyl-D-aspartate receptor-mediated damage in the hippocampus without altering calcium accumulation or extrusion: evidence of calbindin-D28K overexpression. Neuroscience 2001, 102:75-85.
49. Hellstrom-Lindahl E, Court J, Keverne J, Svedberg M, Lee M, Marutle A, Thomas A, Perry E, Bednar I, Nordberg A: Nicotine reduces Abeta in the brain and cerebral vessels of APPsw mice. Eur J Neurosci 2001, 19:2703-2710.
50. Wilkinson DG, Francis PT, Schwam E, Payne-Parrish J: Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy. Drugs Aging 2004, 21:453-78.
51. Wessler I, Reinheimer T, Klapproth H, Schneider FJ, Racke K: Mammalian glial cells in culture synthesize acetylcholine. Naunyn Schmiedebergs Arch Pharmacol 1997, 356:694-7.
52. Fabrizi C, Silei V, Menegazzi M, Salmona M, Bugiani O, Tagliavini F, Suzuki H, Lauro GM: The stimulation of inducible nitric-oxide synthase by the prion protein fragment 106 - 126 in human microglia is tumor necrosis factor-alpha-dependent and involves p38 mitogen-activated protein kinase. J Biol Chem 2001, 276: 25692-25696.
53. Koistinaho M, Koistinaho J: Role of p38 and p44/42 mitogen-activated protein kinases in microglia. Glia 2002, 40:175-183.
54. Fassbender K, Walter S, Kuhl S, Landmann R, Ishii K, Bertsch T, Stalder AK, Muehlhauser F, Liu Y, Ulmer AJ, Rivest S, Lentschat A, Gulbins E, Jucker M, Staufenbiel M, Brechtel K, Walter J, Multhaup G, Penke B, Adachi Y, Hartmann T, Beyreuther K: The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J 2004, 18:203-205.
55. Ajmone-Cat MA, De Simone R, Nicolini A, Minghetti L: Effects of phosphatidylserine on p38 mitogen activated protein kinase, cyclic AMP responding element binding protein and nuclear factor-kappaB activation in resting and activated microglial cells. J Neurochem 2003, 84:413-416.
56. Ajmone-Cat MA, Nicolini A, Minghetti L: Prolonged exposure of microglia to lipopolysaccharide modifies the intracellular signaling pathways and selectively promotes prostaglandin E2 synthesis. J Neurochem 2003, 87:1193-203.
57. Depino AM, Earl C, Kaczmarczyk E, Ferrari C, Besedovsky H, del Rey A, Pitossi FJ, Oertel WH: Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease. Eur J Neurosci 2003, 18:2731-2742.